Human ABC Transporters at blood-CNS Interfaces as Determinants of CNS Drug Penetration

Author(s): Catarina Chaves, Ramzi Shawahna, Aude Jacob, Jean-Michel Scherrmann, Xavier Declèves*

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 10 , 2014

Become EABM
Become Reviewer
Call for Editor


Since the discovery of P-glycoprotein (P-gp) in brain microvessels composing the human blood-brain barrier (BBB), ATPbinding cassette (ABC) transporters have been recognized as bottlenecks in the development and delivery of neuropharmaceuticals. ABC transporters are expressed predominately at the plasma luminal membrane of brain capillary endothelial cells. These ABC transporters are responsible for the efflux of their substrates from the endothelial cells to the bloodstream against the concentration gradient and thus limit the entry of some drugs within the central nervous system (CNS). Advanced quantitative molecular biology tools allowed gene and protein quantification of the components of microvessels isolated from different species including human. Recently, positron emission tomography using radiolabelled probes that are substrates of ABC transporters allowed the determination of their functional activity at the human BBB. Here, we summarized new information regarding the relative expression, substrate recognition pattern for CNS drugs and functional activity of ABC transporters that are quantitatively expressed at the human BBB.

Keywords: ATP-binding cassette transporters, blood-brain barrier, blood-cerebrospinal fluid barrier, P-glycoprotein, breast cancer resistance protein, multidrug resistance protein.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 19 June, 2013
Page: [1450 - 1462]
Pages: 13
DOI: 10.2174/13816128113199990466
Price: $65

Article Metrics

PDF: 66